266 related articles for article (PubMed ID: 14756239)
1. Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice.
Kawana F; Sasaki T
J Electron Microsc (Tokyo); 2003; 52(6):515-25. PubMed ID: 14756239
[TBL] [Abstract][Full Text] [Related]
2. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
Yamazaki H; Sasaki T
J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast differentiation at growth plate cartilage-trabecular bone junction in newborn rat femur.
Sawae Y; Sahara T; Sasaki T
J Electron Microsc (Tokyo); 2003; 52(6):493-502. PubMed ID: 14756237
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of crude bone morphogenetic protein-induced new bone formation and normalization of endochondral ossification by bisphosphonate treatment in osteoprotegerin-deficient mice.
Tabuchi M; Miyazawa K; Kimura M; Maeda H; Kawai T; Kameyama Y; Goto S
Calcif Tissue Int; 2005 Oct; 77(4):239-49. PubMed ID: 16193235
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function.
Shimizu-Ishiura M; Kawana F; Sasaki T
J Electron Microsc (Tokyo); 2002; 51(5):315-25. PubMed ID: 12455916
[TBL] [Abstract][Full Text] [Related]
8. Defective bone remodelling in osteoprotegerin-deficient mice.
Amizuka N; Shimomura J; Li M; Seki Y; Oda K; Henderson JE; Mizuno A; Ozawa H; Maeda T
J Electron Microsc (Tokyo); 2003; 52(6):503-13. PubMed ID: 14756238
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis.
Romas E; Sims NA; Hards DK; Lindsay M; Quinn JW; Ryan PF; Dunstan CR; Martin TJ; Gillespie MT
Am J Pathol; 2002 Oct; 161(4):1419-27. PubMed ID: 12368214
[TBL] [Abstract][Full Text] [Related]
10. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno A; Amizuka N; Irie K; Murakami A; Fujise N; Kanno T; Sato Y; Nakagawa N; Yasuda H; Mochizuki S; Gomibuchi T; Yano K; Shima N; Washida N; Tsuda E; Morinaga T; Higashio K; Ozawa H
Biochem Biophys Res Commun; 1998 Jun; 247(3):610-5. PubMed ID: 9647741
[TBL] [Abstract][Full Text] [Related]
11. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
12. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Boyle WJ; Riggs BL
J Bone Miner Res; 2000 Jan; 15(1):2-12. PubMed ID: 10646108
[TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
14. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
[TBL] [Abstract][Full Text] [Related]
15. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
16. Deletion of beta catenin in hypertrophic growth plate chondrocytes impairs trabecular bone formation.
Golovchenko S; Hattori T; Hartmann C; Gebhardt M; Gebhard S; Hess A; Pausch F; Schlund B; von der Mark K
Bone; 2013 Jul; 55(1):102-12. PubMed ID: 23567158
[TBL] [Abstract][Full Text] [Related]
17. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
[TBL] [Abstract][Full Text] [Related]
18. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
19. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse.
Gruber HE; Rude RK
Biotech Histochem; 2003 Oct; 78(5):231-6. PubMed ID: 14989640
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
